Dengue-Virus Recovery by Direct and Delayed Plaques in LLC-MK2 Cells

Thomas M. YuillDepartment of Virology, Medical Research Laboratory, SEATO Medical Project, Rajavithi Road, Bangkok, Thailand

Search for other papers by Thomas M. Yuill in
Current site
Google Scholar
PubMed
Close
,
Pairatana SukhavachanaDepartment of Virology, Medical Research Laboratory, SEATO Medical Project, Rajavithi Road, Bangkok, Thailand

Search for other papers by Pairatana Sukhavachana in
Current site
Google Scholar
PubMed
Close
,
Ananda NisalakDepartment of Virology, Medical Research Laboratory, SEATO Medical Project, Rajavithi Road, Bangkok, Thailand

Search for other papers by Ananda Nisalak in
Current site
Google Scholar
PubMed
Close
, and
Philip K. RussellDepartment of Virology, Medical Research Laboratory, SEATO Medical Project, Rajavithi Road, Bangkok, Thailand

Search for other papers by Philip K. Russell in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

Summary

A method for detecting and propagating dengue viruses in LLC-MK2 cells has been developed by direct plaquing and by fluid maintenance of inoculated cultures 7 to 14 days before plaquing (delayed plaquing). This procedure was used in support of studies of hemorrhagic fever and has resulted in the recovery of 69 dengue viruses, including all four serotypes. About half of these were detected by delayed plaques when direct plaques were not seen. Most of these dengue strains were inoculated simultaneously into mice and cell cultures. The direct and delayed plaque method was more sensitive and efficient than the use of suckling mice. Comparisons of the direct and delayed plaque method with other methods of recovery of dengue virus are discussed.

Early in the study, occasional difficulty in preparing low-passage cell-culture seed virus of adequate titer was encountered. Consequently, the growth of dengue virus in LLC-MK2 cells was studied. Virus growth was synchronous and cyclic. In order to avoid inadvertent harvesting of virus during eclipse, live cells, rather than cell lysates, were passaged. This has resulted in consistent production of low-passage seed-virus suspensions.

Author Notes

Alternate address: SEATO Medical Project, U.S. Component, APO San Francisco 96346.

Save